FDA product code QLG: Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

QLG is the FDA product code for integrated continuous glucose monitoring system, factory calibrated, not for use with automated insulin delivery systems. It is a Class II device, regulated under 21 CFR 862.1355 and reviewed by the Clinical Chemistry panel. FDA has cleared 9 510(k) submissions under QLG, 4 in the last five years, from 2 different applicants. The average 510(k) review took 223 days (median 215). FDA has posted 10 recalls for QLG devices, 9 initiated in the last five years.

Definition

An integrated continuous glucose monitoring system for replacement of finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes, unless otherwise indicated. The system automatically measures glucose in bodily fluids continuously or frequently for a specified period of time. The system is also designed to reliably and securely transmit glucose measurement data to digitally connected devices and are intended to be used alone or in conjunction with these digitally connected devices where the user manually controls actions for therapy decisions. The system is not intended to be used with automated insulin dosing (AID) systems.

Classification

FieldValue
Device nameIntegrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems
Device classClass II
Regulation21 CFR 862.1355
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)

510(k) clearances per year for QLG

YearClearancesAvg. review days
20201190
20214258
20222240
20232152

Compare with all 510(k) review times · Search every QLG clearance

Top QLG applicants

ApplicantClearancesLatest
Abbott Diabetes Care, Inc.72023-02-21
Bigfoot Biomedical, Inc.22023-03-01

Most recent QLG clearances

510(k)ApplicantDeviceDecision dateReview days
K222280Bigfoot Biomedical, Inc.Bigfoot Unity® Diabetes Management System2023-03-01215
K223537Abbott Diabetes Care, Inc.FreeStyle Libre 2 System, FreeStyle Libre 3 System2023-02-2190
K213996Abbott Diabetes Care, Inc.FreeStyle Libre 3 Continuous Glucose Monitoring System2022-05-26157
K212132Abbott Diabetes Care, Inc.FreeStyle Libre 3 Continuous Glucose Monitoring System2022-05-26322
K210943Abbott Diabetes Care, Inc.FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)2021-11-22237

Recalls for QLG devices

10 product recalls in 7 recall events; 9 initiated in the last five years and 9 still open. Most recent: 2025-11-24.

YearRecalls
20211
20233
20241
20255

Frequently asked questions

What is FDA product code QLG?

QLG is the FDA product code for integrated continuous glucose monitoring system, factory calibrated, not for use with automated insulin delivery systems. It is a Class II device, regulated under 21 CFR 862.1355 and reviewed by the Clinical Chemistry panel.

What device class is QLG?

Class II, regulation 21 CFR 862.1355. Typical premarket route: 510(k).

How long does a 510(k) take for product code QLG?

Across 9 cleared submissions the average was 223 days from receipt to decision (median 215).

Which companies have the most QLG clearances?

Abbott Diabetes Care, Inc. (7); Bigfoot Biomedical, Inc. (2).

Have QLG devices been recalled?

Yes: 10 product recalls across 7 recall events; the most recent began 2025-11-24.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times